Pharmacological characterization of recombinant human and rat P2X receptor subtypes

European Journal of Pharmacology

Volumn 376, Issue 1-2, 1999, Pages 127-138

  Bianchi, Bruce R ^a   Lynch, Kevin J ^a   Touma, Edward ^a   Niforatos, Wende ^a   Burgard, Edward C ^a   Alexander, Karen M ^a   Park, Helen S ^a   Yu, Haixia ^a   Metzger, Randy ^a   Kowaluk, Elizabeth ^a   Jarvis, Michael F ^a   Van Biesen, Tim ^a  

^a ABBOTT LABORATORIES   (United States)

Author keywords

ATP; P2X receptor; Purinergic; Recombinant

Indexed keywords

2 METHYLTHIOADENOSINE TRIPHOSPHATE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ADENOSINE TRIPHOSPHATE DERIVATIVE; ALPHA,BETA METHYLENEADENOSINE TRIPHOSPHATE; DIADENOSINE POLYPHOSPHATE; NUCLEOTIDE DERIVATIVE; PURINE P2X RECEPTOR; PYRIDOXAL PHOSPHATE 6 AZOPHENYL 2',4' DISULFONIC ACID; RECEPTOR SUBTYPE; SURAMIN;

ARTICLE; ASTROCYTOMA CELL; CALCIUM TRANSPORT; DRUG RECEPTOR BINDING; HUMAN; HUMAN CELL; KINETICS; MEMBRANE CURRENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR DENSITY; RECEPTOR DOWN REGULATION;

ADENOSINE TRIPHOSPHATE; ANIMALS; CALCIUM; FLUORESCENCE; HUMANS; KINETICS; OOCYTES; PATCH-CLAMP TECHNIQUES; RATS; RECEPTORS, PURINERGIC P2; RECOMBINANT PROTEINS; TRANSFECTION; TUMOR CELLS, CULTURED; XENOPUS;

EID: 0032988572     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(99)00350-7     Document Type: Article

References (47)

1. 35S ]ADPβS are non-selective for ionotropic or metabotropic P2 receptor subtypes FASEB J. 12:1998;A460.
2. Bo X., Zhang Y., Nassar M., Burnstock G., Schoepfer R. A P2X purinoceptor cDNA conferring a novel pharmacological profile. FEBS Lett. 375:1995;129-133.
3. Brake A.J., Wagenbach M.J., Julius D. New structural motif for ligand-gated ion channels defined by an ionotropic ATP receptor. Nature. 371:1994;519-523.
4. Buell G., Lewis C., Collo G., North R.A., Surprenant A. An antagonist-insensitive P2X receptor expressed in epithelia and brain. EMBO J. 15:1996;55-62.
5. Bultmann R., Wittenburg H., Pause B., Kurz G., Nickel P., Starke K. P2-purinoceptor antagonists: III. Blockade of P2-purinoceptor subtypes and ecto-nucleotidases by compounds related to suramin. Naunyn-Schmiedeberg's Arch. Pharmacol. 354:1996;498-504.
6. Burnstock G. Purinergic nerves. Pharmacol. Rev. 24:1972;509-581.
7. Burnstock G. P2 purinoceptors: historical perspective and classification. Ciba Found. Symp. 198:1996;1-28.
8. Burnstock G., Kennedy C. Is there a basis for distinguishing two types of P2-purinoceptor? Gen. Pharmacol. 16:1985;433-440.
9. Chen C.C., Akopian A.N., Sivilotti L., Colquhoun D., Burnstock G., Wood J.N. A P2X purinoceptor expressed by a subset of sensory neurons. Nature. 377:1995;428-431.
10. Chen B.C., Lee C.M., Lin W.W. Inhibition of ecto-ATPase by PPADS, suramin and reactive blue in endothelial cells, C6 glioma cells and RAW 264.7 macrophages. Br. J. Pharmacol. 119:1996;1628-1634.
11. Chessell I.P., Michel A.D., Humphrey P.P. Properties of the pore-forming P2X7 purinoceptor in mouse NTW8 microglial cells. Br. J. Pharmacol. 121:1997;1429-1437.
12. Chiozzi P., Murgia M., Falzoni S., Ferrari D., Di Virgilio F. Role of the purinergic P2Z receptor in spontaneous cell death in J774 macrophage cultures. Biochem. Biophys. Res. Commun. 218:1996;176-181.
13. Collo G., North R.A., Kawashima E., Merlo-Pich E., Neidhart S., Surprenant A., Buell G. Cloning OF P2X5 and P2X6 receptors and the distribution and properties of an extended family of ATP-gated ion channels. J. Neurosci. 16:1996;2495-2507.
14. Communi D., Boeynaems J.M. Receptors responsive to extracellular pyrimidine nucleotides. Trends Pharmacol. Sci. 18:1997;83-86.
15. Connolly G.P. Differentiation by pyridoxal 5-phosphate, PPADS and IsoPPADS between responses mediated by UTP and those evoked by alpha, beta-methylene-ATP on rat sympathetic ganglia. Br. J. Pharmacol. 114:1995;727-731.
16. Evans R.J., Lewis C., Buell G., Valera S., North R.A., Surprenant A. Pharmacological characterization of heterologously expressed ATP-gated cation channels (P2x purinoceptors). Mol. Pharmacol. 48:1995;178-183.
17. Fredholm B.B., Abbracchio M.P., Burnstock G., Dubyak G.R., Harden T.K., Jacobson K.A., Schwabe U., Williams M. Towards a revised nomenclature for P1 and P2 receptors. Trends Pharmacol. Sci. 18:1997;79-82.
18. Garcia-Guzman M., Soto F., Laube B., Stuhmer W. Molecular cloning and functional expression of a novel rat heart P2X purinoceptor. FEBS Lett. 388:1996;123-127.
19. Garcia-Guzman M., Soto F., Gomez-Hernandez J.M., Lund P.E., Stuhmer W. Characterization of recombinant human P2X4 receptor reveals pharmacological differences to the rat homologue. Mol. Pharmacol. 51:1997;109-118.
20. Garcia-Guzman M., Stuhmer W., Soto F. Molecular characterization and pharmacological properties of the human P2X3 purinoceptor. Brain Res. Mol. Brain Res. 47:1997;59-66.
21. Gargett C.E., Cornish J.E., Wiley J.S. ATP, a partial agonist for the P2Z receptor of human lymphocytes. Br. J. Pharmacol. 122:1997;911-917.
22. Harden T.K., Boyer J.L., Nicholas R.A. P2-purinergic receptors: subtype-associated signaling responses and structure. Annu. Rev. Pharmacol. Toxicol. 35:1995;541-579.
23. Hourani S.M., Hall D.A. P2T purinoceptors: ADP receptors on platelets. Ciba Found. Symp. 198:1996;53-64.
24. Khakh B.S., Humphrey P.P., Surprenant A. Electrophysiological properties of P2X-purinoceptors in rat superior cervical, nodose and guinea-pig coeliac neurones. J. Physiol. (Lond.). 484:1995;385-395. Pt 2.
25. King B.F., Ziganshina L.E., Pintor J., Burnstock G. Full sensitivity of P2X2 purinoceptor to ATP revealed by changing extracellular pH. Br. J. Pharmacol. 117:1996;1371-1373.
26. King B.F., Wildman S.S., Ziganshina L.E., Pintor J., Burnstock G. Effects of extracellular pH on agonism and antagonism at a recombinant P2X2 receptor. Br. J. Pharmacol. 121:1997;1445-1453.
27. Koshimizu T., Tomic M., Van Goor F., Stojilkovic S.S. Functional role of alternative splicing in pituitary P2X2 receptor-channel activation and desensitization. Mol. Endocrinol. 12:1998;901-913.
28. Le K.T., Babinski K., Seguela P. Central P2X4 and P2X6 channel subunits coassemble into a novel heteromeric ATP receptor. J. Neurosci. 18:1998;7152-7159.
29. Leff P., Wood B.E., O'Connor S.E. Suramin is a slowly-equilibrating but competitive antagonist at P2x-receptors in the rabbit isolated ear artery. Br. J. Pharmacol. 101:1990;645-649.
30. Lewis C., Neidhart S., Holy C., North R.A., Buell G., Surprenant A. Coexpression of P2X2 and P2X3 receptor subunits can account for ATP-gated currents in sensory neurons. Nature. 377:1995;432-435.
31. Miras-Portugal M.T., Castro E., Mateo J., Pintor J. The diadenosine polyphosphate receptors: P2D purinoceptors. Ciba Found. Symp. 198:1996;35-47.
32. Miras-Portugal M.T., Gualix J., Pintor J. The neurotransmitter role of diadenosine polyphosphates. FEBS Lett. 430:1998;78-82.
33. Pintor J., Miras-Portugal M.T. A novel receptor for diadenosine polyphosphates coupled to calcium increase in rat midbrain synaptosomes. Br. J. Pharmacol. 115:1995;895-902.
34. Pintor J., Rotllan P., Torres M., Miras-Portugal M.T. Characterization and quantification of diadenosine hexaphosphate in chromaffin cells: granular storage and secretagogue-induced release. Anal. Biochem. 200:1992;296-300.
35. Pintor J., King B.F., Miras-Portugal M.T., Burnstock G. Selectivity and activity of adenine dinucleotides at recombinant P2X2 and P2Y1 purinoceptors. Br. J. Pharmacol. 119:1996;1006-1012.
36. Pintor J., Puche J.A., Gualix J., Hoyle C.H., Miras-Portugal M.T. Diadenosine polyphosphates evoke Ca2+ transients in guinea-pig brain via receptors distinct from those for ATP. J. Physiol. (Lond.). 504:1997;327-335. Pt 2.
37. Radford K.M., Virginio C., Surprenant A., North R.A., Kawashima E. Baculovirus expression provides direct evidence for heteromeric assembly of P2X2 and P2X3 receptors. J. Neurosci. 17:1997;6529-6533.
38. Rassendren F., Buell G.N., Virginio C., Collo G., North R.A., Surprenant A. The permeabilizing ATP receptor, P2X7. Cloning and expression of a human cDNA. J. Biol. Chem. 272:1997;5482-5486.
39. Ripoll C., Martin F., Manuel R.J., Pintor J., Miras-Portugal M.T., Soria B. Diadenosine polyphosphates. A novel class of glucose-induced intracellular messengers in the pancreatic beta-cell. Diabetes. 45:1996;1431-1434.
40. Schachter J.B., Harden T.K. An examination of deoxyadenosine 5′(alpha-thio)triphosphate as a ligand to define P2Y receptors and its selectivity as a low potency partial agonist of the P2Y1 receptor. Br. J. Pharmacol. 121:1997;338-344.
41. Simon J., Kidd E.J., Smith F.M., Chessell I.P., Murrell-Lagnado R., Humphrey P.P., Barnard E.A. Localization and functional expression of splice variants of the P2X2 receptor. Mol. Pharmacol. 52:1997;237-248.
42. Steinberg T.H., Newman A.S., Swanson J.A., Silverstein S.C. ATP4-permeabilizes the plasma membrane of mouse macrophages to fluorescent dyes. J. Biol. Chem. 262:1987;8884-8888.
43. Valera S., Hussy N., Evans R.J., Adami N., North R.A., Surprenant A., Buell G. A new class of ligand-gated ion channel defined by P2x receptor for extracellular ATP. Nature. 371:1994;516-519.
44. Vulchanova L., Riedl M.S., Shuster S.J., Buell G., Surprenant A., North R.A., Elde R. Immunohistochemical study of the P2X2 and P2X3 receptor subunits in rat and monkey sensory neurons and their central terminals. Neuropharmacology. 36:1997;1229-1242.
45. Wildman S.S., King B.F., Burnstock G. Zn2+ modulation of ATP-responses at recombinant P2X2 receptors and its dependence on extracellular pH. Br. J. Pharmacol. 123:1998;1214-1220.
46. Wiley J.S., Chen J.R., Snook M.S., Gargett C.E., Jamieson G.P. Transduction mechanisms of P2Z purinoceptors. Ciba Found. Symp. 198:1996;149-160.
47. Williams, M., Burnstock, G., 1997. Purinergic Neurotransmission and Neuromodulation: A Historical Perspective. Vol. 1. In: Jacobson, K.A., Jarvis, M.F. (Eds.), Purinergic Approaches to Experimental Therapeutics, Wiley-Liss, New York, p. 3.